Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Barratt

Showing results (91-100 of 272) with videos related to

Pageof 28
Sort By:
Journal of the American Society of Nephrology : JASN|August 22, 2025
Authors' Reply: Ravulizumab in IgA Nephropathy: A Promising Step Toward Disease Modification?Jonathan Barratt, Youssef M K Farag, Min Yee, et al.
Pharmaceutical Statistics|November 3, 2023
Conditional power and information fraction calculations at an interim analysis for random coefficient modelsSandra A Lewis, Kevin J Carroll, Todd DeVries, et al.
Expert Opinion on Investigational Drugs|January 2, 2023
IgA nephropathy: an overview of drug treatments in clinical trialsHaresh Selvaskandan, Guillermo Gonzalez-Martin, Jonathan Barratt, et al.
Journal of Clinical Medicine|July 2, 2021
An Update on the Current State of Management and Clinical Trials for IgA NephropathyChee Kay Cheung, Arun Rajasekaran, Jonathan Barratt, et al.
Expert Review of Clinical Immunology|April 27, 2023
Budesonide delayed-release capsules to reduce proteinuria in adults with primary immunoglobulin A nephropathyJonathan Barratt, Richard A Lafayette, Brad H Rovin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 21, 2007
Mutant mice provide new insight into the role of (mis-)glycation in IgA nephropathy and other glomerular diseasesJürgen Floege, Frank Eitner, Jonathan Barratt, et al.
Frontiers in Immunology|October 30, 2020
Monitoring Immune Responses in IgA Nephropathy: Biomarkers to Guide ManagementHaresh Selvaskandan, Sufang Shi, Sara Twaij, et al.
Glomerular Diseases|February 8, 2023
New Insights into the Pathogenesis and Treatment Strategies in IgA NephropathyKatrin Scionti, Karen Molyneux, Haresh Selvaskandan, et al.
Kidney International Reports|January 19, 2026
Complement-Mediated Kidney Diseases: Role of Alternative Pathway in Glomerular InflammationJonathan Barratt, Peter Garred, Richard A Lafayette, et al.
Journal of Clinical Medicine|February 24, 2024
An Update on Current Therapeutic Options in IgA NephropathyRegina Shaoying Lim, See Cheng Yeo, Jonathan Barratt, et al.
Pageof 28

Showing results (91-100 of 272) with videos related to

Sort By:
Pageof 28
Journal of the American Society of Nephrology : JASN|August 22, 2025
Authors' Reply: Ravulizumab in IgA Nephropathy: A Promising Step Toward Disease Modification?Jonathan Barratt, Youssef M K Farag, Min Yee, et al.
Pharmaceutical Statistics|November 3, 2023
Conditional power and information fraction calculations at an interim analysis for random coefficient modelsSandra A Lewis, Kevin J Carroll, Todd DeVries, et al.
Expert Opinion on Investigational Drugs|January 2, 2023
IgA nephropathy: an overview of drug treatments in clinical trialsHaresh Selvaskandan, Guillermo Gonzalez-Martin, Jonathan Barratt, et al.
Journal of Clinical Medicine|July 2, 2021
An Update on the Current State of Management and Clinical Trials for IgA NephropathyChee Kay Cheung, Arun Rajasekaran, Jonathan Barratt, et al.
Expert Review of Clinical Immunology|April 27, 2023
Budesonide delayed-release capsules to reduce proteinuria in adults with primary immunoglobulin A nephropathyJonathan Barratt, Richard A Lafayette, Brad H Rovin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 21, 2007
Mutant mice provide new insight into the role of (mis-)glycation in IgA nephropathy and other glomerular diseasesJürgen Floege, Frank Eitner, Jonathan Barratt, et al.
Frontiers in Immunology|October 30, 2020
Monitoring Immune Responses in IgA Nephropathy: Biomarkers to Guide ManagementHaresh Selvaskandan, Sufang Shi, Sara Twaij, et al.
Glomerular Diseases|February 8, 2023
New Insights into the Pathogenesis and Treatment Strategies in IgA NephropathyKatrin Scionti, Karen Molyneux, Haresh Selvaskandan, et al.
Kidney International Reports|January 19, 2026
Complement-Mediated Kidney Diseases: Role of Alternative Pathway in Glomerular InflammationJonathan Barratt, Peter Garred, Richard A Lafayette, et al.
Journal of Clinical Medicine|February 24, 2024
An Update on Current Therapeutic Options in IgA NephropathyRegina Shaoying Lim, See Cheng Yeo, Jonathan Barratt, et al.
Pageof 28